University of Louisville - Division of Medical Oncology & Hematology | VuMedi

University of Louisville - Division of Medical Oncology & Hematology

University of Louisville - Division of Medical Oncology & Hematology

Louisville Hematology Highlights

Current Standard of Care and Future Directions in CLL

By Louisville Hematology Highlights FEATURING Catherine Coombs

By Louisville Hematology Highlights FEATURING Catherine Coombs

138 views

February 26, 2024

Changes in CLL Treatment & NCCN Guidelines

00:00

BTK Inhibitors Evolution & FDA-Approved Drugs

01:50

ELEVATE TN: Acalabrutinib's Frontline Approval

04:25

SEQUOIA Trial & Zanubrutinib's Frontline Efficacy

08:34

Data from CLL13 and CLL14 Trials

11:27

ELEVATE-RR Trial Compares Acalabrutinib & Ibrutinib

18:47

ALPINE Study & Zanubrutinib vs. Ibrutinib Safety

20:25

Emerging Therapies: Pirtobrutinib & Non-Covalent BTK Inhibitors

23:44

Comments 0

Login to view comments. Click here to Login